Regulatory effects of histamine and histamine receptor expression in human allergic immune responses

Chemical Immunology and Allergy

Volumn 94, Issue , 2008, Pages 67-82

  Akdis, C ^a   Jutel, M ^b   Akdis, M ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR;

ALLERGY; ANTIBODY RESPONSE; ASTHMA; B LYMPHOCYTE; CHRONIC INFLAMMATION; DENDRITIC CELL; HISTAMINE METABOLISM; HUMAN; IMMUNOREGULATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIBODY FORMATION; CELL COMMUNICATION; GRANULOCYTES; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, CELLULAR; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ORGAN SPECIFICITY; RECEPTORS, HISTAMINE; SIGNAL TRANSDUCTION;

EID: 52249118345     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000154858     Document Type: Review

References (98)

1. Akdis CA, Blaser K: Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol 2003;112:15-22.
2. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA: Immune regulation by histamine. Curr Opin Immunol 2002;14:735-740.
3. 1 antihistamines. N Engl J Med 2004;351:2203-2217.
4. Akdis CA, Simons FE: Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006;533:69-76.
5. Dale HH, Laidlaw PP: The physiological action of β- imidazolylethylamine. J Physiol (Lond) 1910;41:318-344.
6. Haas H, Panula P: The role of histamine and the tuberomamillary nucleus in the nervous system. Rev Neurosci 2003;4:121-130.
7. Casale TB, Wood D, Richerson HB, Zehr B, Zavala D, Hunninghake GW: Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction. J Clin Invest 1987;80:1507-1511.
8. Johnson HH Jr, Deoreo GA, Lascheid WP, Mitchell F: Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 1960;34:237-238.
9. Kaplan AP, Horakova Z, Katz SI: Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-354.
10. Tuomisto L, Kilpelainen H, Riekkinen P: Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 1983;13:255-257.
11. Petersen LJ, Hansen U, Kristensen JK, Nielsen H, Skov PS, Nielsen HJ: Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol 1998;78:190-193.
12. Frewin DB, Cleland LG, Jonsson JR, Robertson PW: Histamine levels in human synovial fluid. J Rheumatol 1986;13:13-14.
13. 1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002;32:489-498.
14. Leurs R, Smit MJ, Timmerman H: Molecular and pharmacological aspects of histamine receptors. Pharmacol Ther 1995;66:413-463.
15. 1 receptor signaling. J Exp Med 1999;189:673-682.
16. 2 receptor biology. Am J Physiol 1997;273:G987-G996.
17. 3 receptor. Mol Pharmacol 1999;55:1101-1107.
18. Nakamura K, Kitani A, Strober W: Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J Exp Med 2001;194:629-644.
19. Damaj BB, Becerra CB, Esber HJ, Wen Y, Maghazachi AA: Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J Immunol 2007;179:7907-7915.
20. Kubo Y, Nakano H: Regulation of histamine in mouse CD4+ and CD8+ lymphocytes. Infamm Res 1999;48:149-153.
21. Endo Y: Simultaneous induction of histidine and ornithine decarboxylases and changes in their product amines following the injection of Escherichia coli lipopolysaccharide into mice. Biochem Pharmacol 1982;31:1643-1647.
22. Yoshimoto T, Tsutsui H, Tominaga K, Hoshino K, Okamura H, Akira S, Paul WE, Naknushi K: IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999;96:13962-13966.
23. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G: Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001;502:53-56.
24. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A: Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J Exp Med 2002;196:229-235.
25. Abe Y, Ogino S, Irifune M, Imamura I, Fukui H, Wada H, Matsunaga T: Histamine content, synthesis and degradation in human nasal mucosa. Clin Exp Allergy 1993;23:132-136.
26. 2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest 1993;92:281-287.
27. Meretey K, Falus A, Taga T, Kishimoto T: Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions 1991;33:189-191.
28. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB: Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994;84:2229-2233.
29. Bayram H, Devalia JL, Khair OA, Abdelaziz MM, Sapsford RJ, Czarlewski W, Campbell AM, Bousquet J, Davies RJ: Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol 1999;104:93-99.
30. 1 receptor in cultured human endothelial cells. Biochem Biophys Res Commun 1987;148:47-53.
31. Kubes P, Kanwar S: Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event. J Immunol 1994;152:3570-3577.
32. Yamaki K, Thorlacius H, Xie X, Lindbom L, Hedqvist P, Raud J: Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998;123:390-399.
33. Schaefer U, Schmitz V, Schneider A, Neugebauer E: Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial cells. Shock 1999;12:309-315.
34. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E: Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373-379.
35. Clark RA, Sandler JA, Gallin JI, Kaplan AP: Histamine modulation of eosinophil migration. J Immunol 1977;118:137-145.
36. O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, Fidock M: Identification of a histamine H4 receptor on human eosinophils - role in eosinophil chemotaxis. J Recept Signal Transduct Res 2002;22:431-448.
37. Buckland KF, Williams TJ, Conroy DM: Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 2003;140:1117-1127.
38. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung WP: Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 2004;142:161-171.
39. 1 histamine receptor regulates allergic lung responses. J Clin Invest 2006;116:1624-1632.
40. Seligmann BE, Fletcher MP, Gallin JI: Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 1983;130:1902-1909.
41. 2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest 1993;92:281-287.
42. Bayram H, Devalia JL, Khair OA, Abdelaziz MM, Sapsford RJ, Czarlewski W, Campbell AM, Bousquet J, Davies RJ: Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol 1999;104:93-99.
43. 1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa. J Allergy Clin Immunol 2001;107:123-128.
44. Buckland KF, Williams TJ, Conroy DM: Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 2003;140:1117-1127.
45. 2 receptor. Proc Natl Acad Sci USA 1991;88:5937.
46. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781-36786.
47. Yoneda K, Yamamoto T, Ueta E, Osaki T: Suppression by azelastine hydrochloride of NF-κB activation involved in generation of cytokines and nitric oxide. Jpn J Pharmacol 1997;73:145-153.
48. Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K: Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002;195:973-982.
49. Simons FER: Antihistamines; in Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER (eds): Middleton's Allergy: Principles & Practice. St Louis, Mosby, 2003, pp 834-869.
50. Paolieri F, Battifora M, Riccio AM: Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1988;81:601-607.
51. Caron G, Delneste Y, Roelandts E: Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 2001;166:6000-6006.
52. Casolaro V, Gale D: Functional comparisons of cells obtained from peripheral blood, lung parenchyma, bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989;139:1375-1382.
53. Wenzel SE, Fowler AA, Schwartz LB: Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988;137:1002-1008.
54. Crimi E, Chiaramondia M, Milanese M: Increase of mast cell numbers in mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991;144:1282-1286.
55. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K: Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000;279:615-620.
56. Milligan G, Bond R, Lee M: Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 1995;16:10-13.
57. Malick A, Grant JA: Antihistamines in the treatment of asthma. Allergy 1997;52:55-66.
58. Town GI, Holgate ST: Comparison of the effect of loratadine on the airway and skin responses to histamine, methacholine, and allergen in subjects with asthma. J Allergy Clin Immunol 1990;86:886-893.
59. 2 agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-313.
60. Gelfand EW, Cui ZH, Takeda K, Kanehiro A, Joetham A: Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002;110:85-95.
61. 1 receptors. J Immunol 2001;166:4083-4091.
62. Warner JO: A double-blind, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' post-treatment follow-up. J Allergy Clin Immunol 2001;108:929-937.
63. Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI: Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol 1990;259:L365-L371.
64. Chand N, Eyre P: Classification and biological distribution of histamine receptor subtypes. Agents Actions 1975;5:277-295.
65. 2 receptor antagonist in normal and asthmatic subjects. Thorax 1980;35:428-434.
66. 2-receptor- mediated function in patients with bronchial asthma and ragweed allergy. Chest 1986;89:491-496.
67. Szeberenyi JB, Pallinger E, Zsinko M, Pos Z, Rothe G, Orso E, et al: Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol Lett 2001;76:175-182.
68. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001;108:1865-1873.
69. 2 receptors. J Clin Invest 1998;102:1866-1873.
70. 2 receptors on human monocytes. Clin Immunol 2003;108:274-281.
71. Morichika T, Takahashi HK, Iwagaki H, Yoshino T, Tamura R, Yokoyama M, et al: Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-α production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J Pharmacol Exp Ther 2003;304:624-633.
72. 2 histamine receptors are absent on Langerhans' cells and present on dermal dendritic cells. J Invest Dermatol 2003;121:1073-1079.
73. 2 receptors. Nature 2001;413:420-425.
74. 1. Science 2002;297:620-623.
75. Jarisch R, Goetz M, Aberer W, Sidl R, Stabel A, Zajc J, Fordos A: Reduction of side effects of specific immunotherapy by premedication with antihistamines and reduction of maximal dosage to 50,000 SQ-U/ml. Arbeiten aus dem Paul-Ehrlich Institut 1988;82:163-175.
76. Berchtold E, Maibach R, Muller UR: Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992;22:59-65.
77. Nielsen L, Johnsen CR, Mosbech H, Poulsen L, Malling HJ: Antihistamine premedication in specific cluster immunotherapy: a double-blind placebo-controlled study. J Allergy Clin Immunol 1996;97:1207-1213.
78. Reimers A, Hari Y, Muller UR: Reduction of side effects from ultrarush immunotherapy with honey bee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 2000;55:484-488.
79. Muller U, Hari Y, Berchtold E: Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-86.
80. Jutel M, Zak-Nejmark T, Wrzyyszcz M, Malolepszy J: Histamine receptor expression on peripheral blood CD4+ lymphocytes is influenced by ultrarush bee venom immunotherapy. Allergy 1997;52(suppl 37):88.
81. Diepgen TL: Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol 2002;13:278-286.
82. Akdis CA, Blaser K, Akdis M: Genes of tolerance. Allergy 2004;59:897-913.
83. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K: Role of IL-10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
84. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis C: IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214.
85. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM: Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001;108:1865-1873.
86. Osna N, Elliott K, Khan MM: Regulation of interleukin-10 secretion by histamine in Th2 cells and splenocytes. Int Immunopharmacol 2001;1:85-96.
87. 1-mediated suppression of Th2 responses. FASEB J 2003;17:1089-1095.
88. Gifford R, Schmidke J: Cimetidine-induced augmentation of human lymphocyte blastogenesis: comparison with levamisole in mitogen stimulation. Surg Forum 1979;30:113-115.
89. Simons FER: Allergic rhinobronchitis: the asthma/allergic rhinitis link. J Allergy Clin Immunol 1999;104:543-537.
90. 1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy 1999;29(suppl 3):98-104.
91. 2 agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-313.
92. Bryce PJ, Geha R, Oettgen HC: Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma. J Allergy Clin Immunol 2003;112:149-158.
93. 2-receptor agonists on large and small airways in normal and asthmatic subjects. Br J Dis Chest 1987;81:155-169.
94. Field SK, Sutherland LR: Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? a critical review of the literature. Chest 1998;114:275-283.
95. Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, Bacon KB: Histamine h4 and h2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells. J Pharmacol Exp Ther 2002;303:300-307.
96. 3 receptors: stimulation of IL-10 production. J Immunol 2000;164:2964-2970.
97. 2-adrenergic receptor signaling pathways. J Allergy Clin Immunol 2002;110:S229-S235.
98. 4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 2008;7:41-53.